Proposal to list medical devices supplied by Obex Medical Limited
PHARMAC is seeking feedback on a proposal to list medical devices supplied by Obex Medical Limited in Part III of Section H of the Pharmaceutical Schedule from 1 September 2020.
Closes: 4pm Tuesday 4 August 2020.
Request for Information (RFI) - COVID-19 vaccine research, manufacture and supply
PHARMAC, on behalf of the New Zealand Government COVID-19 vaccine strategy task force, is seeking information regarding COVID-19 vaccine research, manufacture and supply, including supplier willingness to consider a range of different commercial scenarios for supply to New Zealand.
Please provide the information requested in this RFI, and any additional information you consider may be of assistance to PHARMAC via email to procurement@pharmac.govt.nz, no later than 5pm NZT Friday 31 July 2020. And submit any questions via GETS - RFx ID 22954833.
Suppliers are encouraged to raise any queries via the GETS Question and Answer function - please post these on the Government Electronic Tenders Service (www.gets.govt.nz).
Answers to questions will be provided through the Government Electronic Tenders Service (GETS). PHARMAC will also post any addenda through GETS. We encourage interested organisations to register with GETS and subscribe to this RFI to be kept up to date.
Proposal to modify PHARMAC’s approach to competitive procurement
We are proposing to standardise the way that we contract for pharmaceuticals as a result of competitive procurement processes, creating a consistent approach between the community and DHB hospital markets and improving on the methods that we have used for many years.
Closes: 5pm Friday 24 July 2020
Decision to list medical devices supplied by Stryker New Zealand Limited
PHARMAC is pleased to announce the approval of a listing agreement for endomechanical and electrosurgical products, and surgical suction, chest and wound drainage medical devices with Stryker New Zealand Limited for listing on the Pharmaceutical Schedule from 1 August 2020.
Proposal to list medical devices supplied by ConvaTec (New Zealand) Limited
PHARMAC is seeking feedback on a proposal to list a range of feeding equipment and associated devices in Part III of Section H of the Pharmaceutical Schedule from 1 October 2020, through a non-exclusive provisional agreement with ConvaTec (New Zealand) Ltd.
Closes: 5pm Thursday 6 August 2020.
Decision to list medical devices supplied by Baxter Healthcare Limited
We are pleased to announce the approval of a listing agreement with Baxter Healthcare Limited for the supply of haemodialysis equipment and products to DHBs.
PHARMAC to remove medicine dispensing restrictions
Most funded medicines will return to all-at-once dispensing because PHARMAC is removing most of the temporary dispensing restrictions put in place to manage supply during COVID-19. The change will be effective from midnight Friday 31 July 2020.
Proposal to list medical devices supplied by Lohmann & Rauscher Limited
PHARMAC is seeking feedback on a proposal to list medical devices supplied by Lohmann & Rauscher Limited in Part III of Section H of the Pharmaceutical Schedule from 1 September 2020.
Closes: 5pm Thursday 30 July 2020.
Proposal to list medical devices supplied by Cardinal Health Australia Limited
PHARMAC is seeking feedback on a proposal to list Medical Devices supplied by Cardinal Health Australia 503 PTY LTD in Part III of Section H of the Pharmaceutical Schedule from 1 September 2020.
Closes: 5pm Thursday 30 July 2020.
Modifying funded access to mifepristone and misoprostol
PHARMAC is pleased to announce a decision to list mifepristone in Section B of the Pharmaceutical Schedule, enabling it to be supplied on a Practitioners’ Supply Order (PSO); and amend the listing of misoprostol in Section B of the Pharmaceutical Schedule, enabling it to be supplied on a Practitioners’ Supply Order (PSO).
Proposal to list rehabilitation products supplied by Medix 21 Limited
PHARMAC is seeking feedback on a proposal to list rehabilitation equipment, patient positioning products and supports supplied by Medix 21 Limited in Part III of Section H of the Pharmaceutical Schedule from 1 September 2020.
Closes: 4pm Thurday 23 July 2020.
OIA response: Supply chain disruptions caused by COVID-19
All communications and reports regarding supply chain issues caused by COVID-19
OIA response: Cilazapril with hydrochlorothiazide
The number of patients who were dispensed cilazapril with hydrochlorothiazide and other commonly used anti-hypertensives.
OIA response: Lamotrigine brand change
Request for information about the lamotrigine brand change.
June 2020 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2019/20 Invitation to Tender, dated 1 November 2019.
OIA response: Discontinuation of phenelzine sulphate
Request for information about the discontinuation of phenelzine sulphate.
OIA response: Anti-rejection medications for transplant patients
Request for information and statistics on anti-rejection drugs.
OIA response: Utrogestan SA
Request for information on the number of people prescribed Utrogestan SA and the cost of this.
OIA response: Lamotrigine exceptional circumstances applications
Why did the number of declined exceptional circumstances applications for lamotrigine decrease between 5 December 2019 and 18 December 2019?
OIA response: Hospital purchases of special foods
Request for information about DHB reporting about and claiming of rebates for special foods.
Newsletters
Device Advice: Your update on PHARMAC’s Hospital Medical Devices programme.
Media queries
021 863 342
Media phone is monitored 9am–5pm weekdays
